Q1 2015 13F Holders as of 31 Mar 2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
58,643,980
-
Total 13F shares
-
27,941,247
-
Share change
-
+251,410
-
Total reported value
-
$2,635,167,051
-
Put/Call ratio
-
168%
-
Price per share
-
$94.30
-
Number of holders
-
149
-
Value change
-
-$36,991,516
-
Number of buys
-
95
-
Number of sells
-
63
Institutional Holders of AGIOS PHARMACEUTICALS, INC. - Common Stock (AGIO) as of Q1 2015
As of 31 Mar 2015,
AGIOS PHARMACEUTICALS, INC. - Common Stock (AGIO) was held by
149 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
27,941,247 shares.
The largest 10 holders included
FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, Capital World Investors, Flagship Ventures 2007 General Partner LLC, BB BIOTECH AG, VANGUARD GROUP INC, Capital International Investors, BlackRock Fund Advisors, CAPITAL GUARDIAN TRUST CO, and PRICE T ROWE ASSOCIATES INC /MD/.
This page lists
148
institutional shareholders reporting positions in this security
for the Q1 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.